Effect of treatment with Levamisole 1 mM on activated human T-cells
RNA-seq (gene expression) · human · 12 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Homo sapiens (human)
- Samples
- 12 samples: 3 × T-cells, 24-hour activation, Control, Dono vs 3 × T-cells, 24-hour activation, Levamisole 1mM, Dono vs 3 × T-cells, 48-hour activation, Control, Dono vs 3 × T-cells, 48-hour activation, Levamisole 1mM, DonoGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE230683_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA962125 and SRA study SRP434682. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 12 samples.
How we read this: 4 replicated groups read from 12 sample titles; they account for 12 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM7232364 T-cells, 24-hour activation, Control, Donor 1 T-cells, 24-hour activa…
- GSM7232365 T-cells, 24-hour activation, Levamisole 1mM, Donor 1 T-cells, 24-hour activa…
- GSM7232366 T-cells, 24-hour activation, Control, Donor 2 T-cells, 24-hour activa…
- GSM7232367 T-cells, 24-hour activation, Levamisole 1mM, Donor 2 T-cells, 24-hour activa…
- GSM7232368 T-cells, 24-hour activation, Control, Donor 3 T-cells, 24-hour activa…
- GSM7232369 T-cells, 24-hour activation, Levamisole 1mM, Donor 3 T-cells, 24-hour activa…
- GSM7232371 T-cells, 48-hour activation, Control, Donor 1 T-cells, 48-hour activa…
- GSM7232372 T-cells, 48-hour activation, Levamisole 1mM, Donor 1 T-cells, 48-hour activa…
- GSM7232373 T-cells, 48-hour activation, Control, Donor 2 T-cells, 48-hour activa…
- GSM7232374 T-cells, 48-hour activation, Levamisole 1mM, Donor 2 T-cells, 48-hour activa…
- GSM7232375 T-cells, 48-hour activation, Control, Donor 3 T-cells, 48-hour activa…
- GSM7232376 T-cells, 48-hour activation, Levamisole 1mM, Donor 3 T-cells, 48-hour activa…
- GSE342431 Transcriptomic effects of combined AZD4573 and SMAP-2 treatment in resting and anti-CD3/CD28-activated primary human CD4+ T cells 12 samples shares treatment, activated
- GSE292969 Effect of CCS1477 treatment on gene expression in NRF2-activated lung cancer cells 18 samples shares treatment, activated
- GSE283522 The spatially informed mFISHseq assay resolves biomarker discordance and predicts treatment response in breast cancer 1254 samples shares treatment
- GSE279719 Human CD14+ monocytes from early inflammatory arthritis patients before and after a 5day-and 30day-period of methotrexate treatment 72 samples shares treatment
- GSE282580 Colon tissue gene expression associated with vedolizumab treatment effectiveness in ulcerative colitis. 60 samples shares treatment
- GSE319641 RNA-Seq profiling of pre- and on-treatment tumor samples from breast cancer patients enrolled in the NeoTRIP trial. 401 samples shares treatment
- GSE222196 Treatment of prostate cancer cell lines with Androgen Receptor and Receptor Tyrosine Kinase inhibitors 246 samples shares treatment
- GSE282122 A longitudinal single-cell atlas of anti-tumour necrosis factor treatment in inflammatory bowel disease 216 samples shares treatment
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.